Ted Echemann is an accomplished leader in the oncology and healthcare sectors, currently serving as Director of Oncology Collaborations at Natera since September 2024. Previously, Ted held the position of Key Account Director for Health System Partnerships at GRAIL, where efforts focused on building partnerships to enhance patient access to testing and contribute to revenue growth. Prior roles include Vice President of US Sales at IDBYDNA INC, where strategic engagements drove growth before the company's acquisition by Illumina, and various sales leadership positions at CIRCULOGENE, Mitra Biotech, Foundation Medicine, and Helomics. Ted's career reflects a strong emphasis on fostering collaborations in oncology, along with a robust sales and marketing background solidified through a BS in Marketing from Southern Illinois University, Carbondale.